Addictions therapeutics market seen reaching $10.24 billion by 2030

The addictions therapeutics market is projected to grow from $7.46 billion in 2025 to $7.93 billion in 2026, with North America holding the largest regional share. The Business Research Company says rising alcohol use, telehealth adoption and broader treatment access are helping drive demand.

Why it matters: - The addictions therapeutics market is expanding as substance use disorders drive demand for medications, counseling and relapse-prevention care. - Faster growth could support more access to medication-assisted treatment, telehealth and integrated mental health services. - The market forecast also signals continued spending on addiction care by public and private buyers.

What happened: - The Business Research Company published its Global Market Report 2026 for addictions therapeutics, covering market size, trends and forecasts through 2035. - The market is projected to rise from $7.46 billion in 2025 to $7.93 billion in 2026, a 6.2% compound annual growth rate. - The report projects the market will reach $10.24 billion by 2030, at a 6.6% compound annual growth rate. - North America held the largest share of the market in 2025.

The details: - Addictions therapeutics includes medications, treatments and management strategies for substance use disorders and other addictions. - The therapies often include group and individual counseling to support recovery and prevent relapse. - Historical growth has been supported by rising substance use disorders, greater awareness of addiction treatment, more specialized treatment centers, wider use of buprenorphine and naltrexone, and expansion of hospital and clinical facilities. - Future growth is expected to come from innovation in addiction therapeutics, more government and private funding, telehealth and digital treatment platforms, integration of mental health and addiction care, and more public-private partnerships. - The report highlights rising demand for medication-assisted treatment, growth in inpatient and outpatient addiction centers, wider use of telehealth and remote counseling, greater focus on nicotine and opioid addiction therapies, and more awareness campaigns. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - The report is available with a free sample and the full report.

Between the lines: - Rising alcohol consumption is a key demand driver because alcohol dependence often requires medical intervention. - Addiction therapeutics can reduce cravings and manage withdrawal symptoms such as insomnia, anxiety and restlessness. - The report points to beer consumption as a proxy for wider alcohol demand, citing Kirin Holdings’ disclosure that global beer consumption rose by about 200,000 kiloliters in 2023 to about 187.9 million kiloliters, up 0.1% from 2022. - The market’s emphasis on telehealth and remote counseling suggests providers are moving toward lower-friction, more scalable care models. - A stronger focus on nicotine and opioid therapies reflects where addiction treatment demand remains most acute.

What's next: - The market is expected to keep growing as funding, digital care and integrated treatment models expand. - Future report updates are likely to track changes in treatment delivery, regional demand and competition across addiction care segments. - North America’s lead may remain important as other regions scale treatment access and digital delivery.

The bottom line: - Addictions therapeutics is a steady-growth healthcare market, with alcohol use, telehealth and medication-assisted treatment shaping the next phase of expansion.